The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...

Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...

FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S.

BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...

Becton, Dickinson and Company (BD) has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US. This ...

The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...

FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today issued the following statement regarding the March 19, ...

Becton Dickinson ($BDX) is buying California's Safety Syringes, a maker of anti-needlestick devices, looking to bolster its injectable offerings. BD didn't disclose ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...

FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper. FDA alerted healthcare ...